FRESENIUS KABI USA LLC

• FRESENIUS KABI USA LLC $3,867,941 In-house, the client's own filings · 7 filings
• FEROX STRATEGIES $350,000 Outside firm · 8 filings
• CGCN GROUP, LLC $230,000 Outside firm · 6 filings
• DB3, LLC (FKA THE DASCHLE GROUP) $50,000 Outside firm · 2 filings
• WILEY REIN LLP $10,000 Outside firm · 2 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 3269
  ETHIC Act
  7 filings
• S. 2276
  ETHIC Act
  7 filings
• H.R. 5526
  Biosimilar Red Tape Elimination Act
  4 filings
• S. 1414
  Expedited Access to Biosimilars Act
  4 filings
• S. 1954
  Biosimilar Red Tape Elimination Act
  4 filings
• S. 43
  Skinny Labels, Big Savings Act
  4 filings
• S. 2658
  Medication Affordability and Patent Integrity Act
  3 filings
• H.R. 6485
  Skinny Labels, Big Savings Act
  2 filings
• S. 2305
  Biosimilar Red Tape Elimination Act
  1 filing
• H.R. 10369
  Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
  1 filing
• H.R. 2214
  DRUG Act
  1 filing
• H.R. 3160
  PREVAIL Act
  1 filing
• H.R. 4317
  PBM Reform Act of 2025
  1 filing
• H.R. 4570
  Interagency Patent Coordination and Improvement Act of 2025
  1 filing
• H.R. 6837
  To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are con…
  1 filing
• S. 1041
  Affordable Prescriptions for Patients Act
  1 filing
• S. 1096
  Preserve Access to Affordable Generics and Biosimilars Act
  1 filing
• S. 1097
  Interagency Patent Coordination and Improvement Act of 2025
  1 filing
• S. 1553
  PREVAIL Act
  1 filing
• S. 2296
  National Defense Authorization Act for Fiscal Year 2026
  1 filing
• S. 3549
  PBM FAIR Act
  1 filing

• 2026 $2,670,000 13 filings
• 2025 $1,837,941 12 filings

• Trade (domestic/foreign) 18
• Health Issues 17
• Manufacturing 13
• Pharmacy 12
• Taxation/Internal Revenue Code 10
• Tariff (miscellaneous tariff bills) 8
• Medicare/Medicaid 7
• Copyright/Patent/Trademark 5
• Budget/Appropriations 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 21
• SENATE 21
• Health & Human Services, Dept of (HHS) 15
• Commerce, Dept of (DOC) 14
• U.S. Trade Representative (USTR) 12
• Executive Office of the President (EOP) 9
• White House Office 9
• Centers For Medicare and Medicaid Services (CMS) 6
• Food & Drug Administration (FDA) 6
• Labor, Dept of (DOL) 4
• Patent & Trademark Office (PTO) 4
• Natl Economic Council (NEC) 3
• Office of Management & Budget (OMB) 3
• Defense, Dept of (DOD) 2
• Veterans Affairs, Dept of (VA) 1

• FRESENIUS KABI SWISSBIOSIM GMBH Switzerland named on 2 filings · highest disclosed ownership 100% · largest disclosed contribution $0
• FRESENIUS SE KGA Germany named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.